BioNTech/Comirnaty Covid-19 vaccines are currently available. Read more at straitstimes.com. Read more at straitstimes.com.
Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may translate into big problems for Johnson & Johnson, Merck, and other ...
Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...
Stocktwits on MSN
Novavax Stock Faces Retail Backlash As Shah Capital Warns Of Proxy Fight And Presses For A Sale
Shah Capital increased its stake to about 8.3% and said the gap between Novavax’s scientific potential and its commercial ...
The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...
TAIPEI (Taiwan News) — Taiwan's Centers for Disease Control said Tuesday that 101,100 people sought emergency room treatment for flu-like illness last week, a 7.5% decrease from the previous week.
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...
IAVI reports its single-dose Lassa fever vaccine is safe and effective, paving way for advanced trials across West Africa.
Novavax Inc (NVAX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial Challenges
Novavax Inc (NVAX) focuses on innovation and partnerships amid financial hurdles, aiming for profitability by 2028.
TipRanks on MSN
Novavax’s Q3 2025 Earnings Call: Optimistic Outlook
Novavax (($NVAX)) has held its Q3 earnings call. Read on for the main highlights of the call. Novavax’s Q3 2025 Earnings Call: A Cautiously ...
Novavax on Thursday provided preliminary adjusted revenue for 2026 and pushed back its profitability target by a year to 2028 as the biotech awaits key product launches from its partnership with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results